Matrix Metalloproteinase 7
"Matrix Metalloproteinase 7" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The smallest member of the MATRIX METALLOPROTEINASES. It plays a role in tumor progression.
| Descriptor ID |
D020783
|
| MeSH Number(s) |
D08.811.277.656.300.480.525.700.250 D08.811.277.656.675.374.525.700.250 D12.644.276.848.250 D12.776.467.836.250
|
| Concept/Terms |
Matrix Metalloproteinase 7- Matrix Metalloproteinase 7
- Metalloproteinase 7, Matrix
- Matrilysin
- MMP7 Metalloproteinase
- Metalloproteinase, MMP7
- MMP-7 Metalloproteinase
- MMP 7 Metalloproteinase
- Metalloproteinase, MMP-7
- Matrix Metalloproteinase-7
- Metalloproteinase-7, Matrix
|
Below are MeSH descriptors whose meaning is more general than "Matrix Metalloproteinase 7".
Below are MeSH descriptors whose meaning is more specific than "Matrix Metalloproteinase 7".
This graph shows the total number of publications written about "Matrix Metalloproteinase 7" by people in this website by year, and whether "Matrix Metalloproteinase 7" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 1 | 2 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 1 | 2 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Matrix Metalloproteinase 7" by people in Profiles.
-
Induction of Cellular Senescence in Rat Vaginal Fibroblasts and Treatment With Senolytics: An in Vitro Model for the Study of Pelvic Organ Prolapse. Female Pelvic Med Reconstr Surg. 2022 05 01; 28(5):341-345.
-
14-3-3 proteins modulate the ETS transcription factor ETV1 in prostate cancer. Cancer Res. 2013 Aug 15; 73(16):5110-9.
-
Proteomic analysis of the left ventricle post-myocardial infarction to identify in vivo candidate matrix metalloproteinase substrates. Methods Mol Biol. 2013; 1066:185-99.
-
ETS variant 1 regulates matrix metalloproteinase-7 transcription in LNCaP prostate cancer cells. Oncol Rep. 2013 Jan; 29(1):306-14.
-
The matrix metalloproteinase-7 polymorphism rs10895304 is associated with increased recurrence risk in patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 2011 Apr 01; 79(5):1330-5.
-
GPCR agonist-induced transactivation of the EGFR upregulates MLC II expression and promotes hypertension in insulin-resistant rats. Cardiovasc Res. 2010 Jul 01; 87(1):177-86.
-
Maintenance of adrenergic vascular tone by MMP transactivation of the EGFR requires PI3K and mitochondrial ATP synthesis. Cardiovasc Res. 2009 Dec 01; 84(3):368-77.
-
Concerted activation of the Mdm2 promoter by p72 RNA helicase and the coactivators p300 and P/CAF. J Cell Biochem. 2007 Aug 01; 101(5):1252-65.
-
Activation of gelatinase-tissue-inhibitors-of-metalloproteinase complexes by matrilysin. Biochem J. 1998 May 01; 331 ( Pt 3):965-72.